- Report
- October 2024
- 189 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- October 2024
- 199 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- July 2024
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2025
- 92 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 194 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- May 2024
- 137 Pages
Global
From €5915EUR$6,499USD£5,024GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1138EUR$1,250USD£966GBP
- Report
- December 2024
Japan, United States, ... Japan, United States, Europe, Global
From €16838EUR$18,500USD£14,302GBP
- Report
- February 2025
Global, Europe, United States, ... Global, Europe, United States, Japan
From €3413EUR$3,750USD£2,899GBP
- Report
- December 2024
United States
From €2275EUR$2,500USD£1,933GBP
- Report
- December 2024
North America, Mexico, ... North America, Mexico, Canada
From €8647EUR$9,500USD£7,344GBP
- Report
- February 2025
Middle East
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2025
North America, Mexico, ... North America, Mexico, Canada
From €2230EUR$2,450USD£1,894GBP
- Report
- February 2025
Europe, United Kingdom, ... Europe, United Kingdom, Spain, Italy, Germany, France
From €2594EUR$2,850USD£2,203GBP
- Report
- February 2025
United States
From €1320EUR$1,450USD£1,121GBP
- Report
- May 2023
- 140 Pages
Global
From €4504EUR$4,949USD£3,826GBP

Fibrinogen is a hematological drug used to treat bleeding disorders. It is a glycoprotein found in the blood that helps form a clot when a person is bleeding. Fibrinogen is produced in the liver and is essential for normal blood clotting. When a person has a deficiency of fibrinogen, they may experience excessive bleeding. Fibrinogen replacement therapy is used to treat this condition.
Fibrinogen replacement therapy is used to treat a variety of conditions, including congenital fibrinogen deficiency, acquired fibrinogen deficiency, and bleeding disorders. It is also used to treat bleeding associated with surgery, trauma, and childbirth.
The fibrinogen market is highly competitive, with several companies offering products for the treatment of bleeding disorders. Some of the major players in the market include CSL Behring, Grifols, Octapharma, Kedrion, and Shire. These companies offer a range of products, including fibrinogen concentrates, fibrinogen replacement therapies, and fibrinogen-based products. Show Less Read more